NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 283 filers reported holding NEOGENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,694,555 | -43.5% | 462,972 | -26.2% | 0.00% | -50.0% |
| Q2 2023 | $10,087,413 | -62.3% | 627,717 | -59.2% | 0.00% | -60.0% |
| Q1 2023 | $26,771,444 | +336.9% | 1,537,705 | +131.9% | 0.01% | +400.0% |
| Q4 2022 | $6,127,829 | -45.9% | 663,185 | -49.6% | 0.00% | -50.0% |
| Q3 2022 | $11,327,000 | +30.0% | 1,315,483 | +23.0% | 0.00% | 0.0% |
| Q2 2022 | $8,716,000 | -11.7% | 1,069,425 | +31.6% | 0.00% | 0.0% |
| Q1 2022 | $9,870,000 | -28.3% | 812,363 | +101.4% | 0.00% | 0.0% |
| Q4 2021 | $13,759,000 | +210.4% | 403,269 | +338.9% | 0.00% | – |
| Q3 2021 | $4,432,000 | -43.7% | 91,877 | -47.3% | 0.00% | -100.0% |
| Q2 2021 | $7,872,000 | -18.5% | 174,265 | -13.0% | 0.00% | 0.0% |
| Q1 2021 | $9,656,000 | -23.1% | 200,218 | -14.2% | 0.00% | -50.0% |
| Q4 2020 | $12,563,000 | +119.9% | 233,340 | +50.7% | 0.00% | +100.0% |
| Q3 2020 | $5,712,000 | +109.8% | 154,835 | +76.1% | 0.00% | – |
| Q2 2020 | $2,723,000 | -58.4% | 87,900 | -63.0% | 0.00% | -100.0% |
| Q1 2020 | $6,551,000 | +9.4% | 237,301 | +16.0% | 0.00% | 0.0% |
| Q4 2019 | $5,986,000 | -0.7% | 204,632 | -35.1% | 0.00% | +50.0% |
| Q3 2019 | $6,030,000 | +1.9% | 315,396 | +16.9% | 0.00% | -33.3% |
| Q2 2019 | $5,919,000 | +867.2% | 269,784 | +802.3% | 0.00% | – |
| Q1 2019 | $612,000 | -93.6% | 29,900 | -96.1% | 0.00% | -100.0% |
| Q4 2018 | $9,561,000 | +48.3% | 758,123 | +80.5% | 0.01% | +66.7% |
| Q3 2018 | $6,449,000 | +15.6% | 420,028 | -1.3% | 0.00% | 0.0% |
| Q2 2018 | $5,578,000 | +84.3% | 425,480 | +14.7% | 0.00% | +50.0% |
| Q1 2018 | $3,027,000 | +51.5% | 370,894 | +64.5% | 0.00% | +100.0% |
| Q4 2017 | $1,998,000 | -19.5% | 225,454 | +1.1% | 0.00% | -50.0% |
| Q3 2017 | $2,481,000 | -3.6% | 222,920 | -22.4% | 0.00% | 0.0% |
| Q2 2017 | $2,573,000 | +128.3% | 287,196 | +101.1% | 0.00% | +100.0% |
| Q1 2017 | $1,127,000 | +189.0% | 142,795 | +213.6% | 0.00% | – |
| Q4 2016 | $390,000 | -69.3% | 45,537 | -70.5% | 0.00% | -100.0% |
| Q3 2016 | $1,269,000 | +5.8% | 154,363 | +3.5% | 0.00% | 0.0% |
| Q2 2016 | $1,199,000 | +1327.4% | 149,104 | +1099.2% | 0.00% | – |
| Q1 2016 | $84,000 | -78.7% | 12,434 | -75.2% | 0.00% | – |
| Q4 2015 | $395,000 | +74.0% | 50,177 | +26.6% | 0.00% | – |
| Q3 2015 | $227,000 | +70.7% | 39,630 | +61.8% | 0.00% | – |
| Q2 2015 | $133,000 | -87.0% | 24,500 | -88.8% | 0.00% | -100.0% |
| Q1 2015 | $1,023,000 | +8.9% | 219,156 | -2.7% | 0.00% | 0.0% |
| Q4 2014 | $939,000 | +18.0% | 225,125 | +47.3% | 0.00% | 0.0% |
| Q3 2014 | $796,000 | +6.8% | 152,842 | -31.9% | 0.00% | 0.0% |
| Q2 2014 | $745,000 | +69.7% | 224,291 | +77.2% | 0.00% | 0.0% |
| Q1 2014 | $439,000 | +41.6% | 126,591 | +47.6% | 0.00% | – |
| Q4 2013 | $310,000 | +297.4% | 85,771 | +231.7% | 0.00% | – |
| Q3 2013 | $78,000 | – | 25,855 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |